JPY 2714.0
(2.16%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 13.64 Billion JPY | -59.75% |
2022 | 43.07 Billion JPY | -31.95% |
2021 | 65.11 Billion JPY | 66.21% |
2020 | 37.88 Billion JPY | 105.04% |
2019 | 21.27 Billion JPY | -14.36% |
2018 | 24.35 Billion JPY | -61.03% |
2017 | 2.88 Billion JPY | 35.04% |
2016 | 41.18 Billion JPY | 1.55% |
2015 | 41.04 Billion JPY | -7.11% |
2014 | 40.29 Billion JPY | 0.42% |
2013 | 41.31 Billion JPY | 4.37% |
2012 | 39.47 Billion JPY | 11.98% |
2011 | 34.82 Billion JPY | 10.66% |
2010 | 30.28 Billion JPY | 9.42% |
2009 | 28.96 Billion JPY | 11.57% |
2008 | 25.79 Billion JPY | 6.2% |
2007 | 23.9 Billion JPY | 4.03% |
2006 | 23.53 Billion JPY | -61.53% |
2005 | 22 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 5.68 Billion JPY | 376.19% |
2023 Q4 | 2.57 Billion JPY | -27.34% |
2023 FY | - JPY | -59.75% |
2023 Q2 | 5.25 Billion JPY | 30.12% |
2023 Q3 | 3.54 Billion JPY | -32.61% |
2023 Q1 | 4.03 Billion JPY | -2.61% |
2022 Q3 | 10.47 Billion JPY | -26.16% |
2022 Q1 | 12.99 Billion JPY | -20.76% |
2022 FY | - JPY | -31.95% |
2022 Q4 | 4.14 Billion JPY | -60.43% |
2022 Q2 | 14.18 Billion JPY | 9.13% |
2021 Q1 | 14.75 Billion JPY | 35.0% |
2021 FY | - JPY | 66.21% |
2021 Q3 | 12.48 Billion JPY | -29.79% |
2021 Q4 | 16.4 Billion JPY | 31.36% |
2021 Q2 | 17.78 Billion JPY | 20.57% |
2020 FY | - JPY | 105.04% |
2020 Q1 | 3.31 Billion JPY | -2.87% |
2020 Q2 | 10.08 Billion JPY | 203.77% |
2020 Q3 | 12.63 Billion JPY | 25.29% |
2020 Q4 | 10.92 Billion JPY | -13.49% |
2019 Q3 | 4.49 Billion JPY | -10.61% |
2019 Q4 | 3.41 Billion JPY | -23.9% |
2019 FY | - JPY | -14.36% |
2019 Q1 | 5.09 Billion JPY | 15.92% |
2019 Q2 | 5.02 Billion JPY | -1.43% |
2018 Q4 | 4.39 Billion JPY | -29.1% |
2018 FY | - JPY | -61.03% |
2018 Q3 | 6.2 Billion JPY | 16.24% |
2018 Q1 | 5.11 Billion JPY | 31.37% |
2018 Q2 | 5.33 Billion JPY | 4.22% |
2017 Q1 | 9.62 Billion JPY | 12.0% |
2017 FY | - JPY | 35.04% |
2017 Q4 | 3.89 Billion JPY | -87.98% |
2017 Q3 | 32.4 Billion JPY | 300.72% |
2017 Q2 | 8.08 Billion JPY | -15.96% |
2016 Q1 | 9.79 Billion JPY | 16.58% |
2016 Q4 | 8.59 Billion JPY | -22.6% |
2016 Q2 | 10.5 Billion JPY | 7.27% |
2016 Q3 | 11.1 Billion JPY | 5.64% |
2016 FY | - JPY | 1.55% |
2015 Q4 | 8.4 Billion JPY | -18.92% |
2015 FY | - JPY | -7.11% |
2015 Q3 | 10.36 Billion JPY | -0.55% |
2015 Q1 | 10.19 Billion JPY | 8.27% |
2015 Q2 | 10.41 Billion JPY | 2.17% |
2014 Q2 | 11.49 Billion JPY | 9.1% |
2014 Q3 | 10.95 Billion JPY | -4.72% |
2014 Q4 | 9.41 Billion JPY | -13.98% |
2014 FY | - JPY | 0.42% |
2014 Q1 | 10.53 Billion JPY | 6.62% |
2013 Q2 | 11.05 Billion JPY | 4.34% |
2013 Q3 | 10.69 Billion JPY | -3.23% |
2013 Q4 | 9.88 Billion JPY | -7.62% |
2013 FY | - JPY | 4.37% |
2013 Q1 | 10.59 Billion JPY | 16.06% |
2012 Q4 | 9.12 Billion JPY | -12.32% |
2012 Q1 | 11.07 Billion JPY | 17.14% |
2012 FY | - JPY | 11.98% |
2012 Q2 | 9.84 Billion JPY | -11.14% |
2012 Q3 | 10.4 Billion JPY | 5.75% |
2011 FY | - JPY | 10.66% |
2011 Q1 | 8.7 Billion JPY | 14.3% |
2011 Q4 | 9.45 Billion JPY | 2.66% |
2011 Q2 | 8.75 Billion JPY | 0.56% |
2011 Q3 | 9.21 Billion JPY | 5.21% |
2010 FY | - JPY | 9.42% |
2010 Q4 | 7.61 Billion JPY | -9.57% |
2010 Q1 | 8.59 Billion JPY | 31.93% |
2010 Q2 | 8.02 Billion JPY | -6.69% |
2010 Q3 | 8.42 Billion JPY | 5.01% |
2009 Q1 | 7.49 Billion JPY | 11.97% |
2009 FY | - JPY | 11.57% |
2009 Q4 | 6.51 Billion JPY | -18.26% |
2009 Q3 | 7.97 Billion JPY | 1.31% |
2009 Q2 | 7.86 Billion JPY | 4.98% |
2008 Q3 | 7 Billion JPY | 69.61% |
2008 FY | - JPY | 6.2% |
2008 Q4 | 6.69 Billion JPY | -4.45% |
2008 Q2 | 4.13 Billion JPY | 0.0% |
2007 FY | - JPY | 4.03% |
2006 FY | - JPY | -61.53% |
2005 FY | - JPY | 0.0% |
2004 Q4 | 5.65 Billion JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 8.98 Billion JPY | -51.951% |
DNA Chip Research Inc. | -217 Million JPY | 6388.94% |
Cosmo Bio Company,Limited | 669 Million JPY | -1939.91% |
FALCO HOLDINGS Co., Ltd. | 3.13 Billion JPY | -335.728% |
BML, Inc. | 16.41 Billion JPY | 16.883% |
Human Metabolome Technologies, Inc. | 306.48 Million JPY | -4352.761% |
Precision System Science Co., Ltd. | -661.75 Million JPY | 2162.259% |